Q301--ThyroSeq v3 Genomic Classifier Sole Source Notice
Veterans Affairs · 250-NETWORK CONTRACT OFFICE 10 (36C250)
Capture briefs (a one-page, shareable copy of this page) are part of Pro. The CSV here holds the notice, its timeline and past awards.
Where this opportunity stands
Every notice posted under solicitation 36C25025Q0934 in this department, oldest first.
- Sep 15, 2025 · this noticeSpecial Notice
- Oct 6, 2025Award NoticeCYTOPATH BIOPSY LAB INC · $387KOpen
- Oct 6, 2025Justification (Sole Source)CYTOPATH BIOPSY LAB INC · $387KOpen
Next steps for this stage
Standard steps for the notice type; not advice about this buyer.
- Answer the notice: this is when the requirement can still be shaped.
- Contact the contracting officer named on the notice.
- Check who won similar work; they are the likely bidders.
What the notice says
The Department of Veterans Affairs, Network 10 Contracting Office, in accordance with FAR 13.106-1(b)(1)(i) Exclusive Licensing, intends to negotiate on a single source basis a base plus four, one-year option years, firm fixed price contract with CBL Path, 760 Westchester Ave, Rye Brook, New York, 10573 to provide the ThyroSeq v3 Genomic Classifier for the Richard L. Roudebush VA Medical Center. NAICS Code is 621511, and Size Standard is $41.5 Million. This notice of intent is not a request for competitive proposals, solicitations, or request for offers. No solicitation package is available. A… (show all)
determination not to compete is solely within the discretion of the Government. Any response to this notice must show clear and convincing evidence that competition would be advantageous to the Government. No telephone inquiries will be accepted. Responses must be submitted by 10:00AM EDT, September 18, 2025, and shall be sent via email to Jessica.Bryant5@va.gov.
Who won similar work
8 award notices on SAM.gov in the last 24 months. Matched by: Same office (250-NETWORK CONTRACT OFFICE 10 (36C250)), same product/service code (PSC) Q301 and NAICS 621511.
Single-winner award sizes (8): middle half $219K to $3.1M, median $1.3M; range $130K to $4.6M.
| Winner | Awards | Value | Last |
|---|---|---|---|
| LABORATORY CORPORATION | 4 | $13.7M | Aug 31, 2026 |
| MAYO COLLABORATIVE SERVICES, INC. | 1 | $275K | Apr 20, 2026 |
| ADAPTIVE BIOTECHNOLOGIES CORPORATION · $ADPT · $308.1M | 1 | $244K | Dec 30, 2025 |
| CYTOPATH BIOPSY LAB INC | 1 | $146K | Dec 23, 2025 |
| VERACYTE LABS SD CORPORATION · $VCYT · $561.9M | 1 | $130K | Nov 19, 2025 |
Value counts single-winner awards. "Shared" awards are multiple-award contracts that list every winner with the same total ceiling; that ceiling is not one company's win, so it is not added in. Revenue next to a ticker is the company's last annual revenue from its 10-K.
- $ADPT reported $308.1M revenue (12 months to Jun 30, 2026). The median single-winner award in these 8 past awards, $1.3M, is 0.4% of that. SEC filing
- $VCYT reported $561.9M revenue (12 months to Jun 30, 2026). The median single-winner award in these 8 past awards, $1.3M, is 0.2% of that. SEC filing
One award's total value against one year of revenue; many awards are paid over several years.
- Aug 31, 2026LABORATORY CORPORATION$4.6MQ301--Reference Lab Services - BCVAMC &WCBOCNo listed company matched (Materiality N/A)
- Aug 13, 2026LABORATORY CORPORATION$2.3MQ301--Reference Lab Services - SaginawNo listed company matched (Materiality N/A)
- Jul 17, 2026LABORATORY CORPORATION$2.7MQ301--Reference Lab Services - DetroitNo listed company matched (Materiality N/A)
- Apr 20, 2026MAYO COLLABORATIVE SERVICES, INC.$275KEsoteric Lab TestingNo listed company matched (Materiality N/A)
- Dec 30, 2025ADAPTIVE BIOTECHNOLOGIES CORPORATION$244KQ301 - ClonoSEQ Measurable Residual Disease (MRD) Testing ServicesMateriality: 0.08% of $ADPT revenue (Low) SEC
- Dec 23, 2025CYTOPATH BIOPSY LAB INC$146KQ301 - Thyro Seq v3 Genomic Classifier (GC) TestingNo listed company matched (Materiality N/A)
- Nov 19, 2025VERACYTE LABS SD CORPORATION$130KQ301--Decipher Prostate Testing Base- Ann Arbor, Battle Creek and SaginawMateriality: 0.02% of $VCYT revenue (Low) SEC
- Jun 30, 2025LABORATORY CORPORATION$4.0MQ301--Indy Reference Laboratory TestingNo listed company matched (Materiality N/A)
Materiality: one award's value as a share of the winner's revenue over the latest 12 months in its SEC filings (or its last fiscal year, as noted when you point at it). Low under 1%, Medium 1 to 5%, High 5% or more. Many awards are paid over several years, so this overstates a single year's share.
Competitive landscape
For the 5 most frequent past winners above. Lobbying is matched by the company's exact name or exact ticker; agencies are as named on the filings.
- 0 of these past winners lobbied Veterans Affairs, Dept of (VA) since 2024 (0 filings)
- 0 of their lobbyists list a past Veterans Affairs, Dept of (VA) job
- No corporate PAC money from them to the overseeing committees since 2024
- 0 foreign-agent (FARA) registrations
Policy around it
Bills the past winners named while lobbying this agency's issues, rules from the department, and executive orders that name the agency, last 12 months.
- 0 bills named on the past winners' lobbying filings
- 25 rules from the department in the last 12 months
- 0 executive orders naming the agency in the last 12 months
Market
For past winners matched exactly to a listed company. Insider trades are open-market buys and sells (Form 4) in the last 90 days, shown as facts; our own study found insiders do not reliably buy ahead of awards. A sale marked 10b5-1 was made under a trading plan set up in advance.
- 2 of the past winners are listed companies
- 0 insider buys and 14 insider sells at them in the last 90 days
Sources: SAM.gov notices and award notices; Senate LDA lobbying filings; FEC filings; FARA; Federal Register; congress.gov; SEC Form 4. Every row above links to its record.
Companies are matched to tickers by exact name only. A company we could not match shows no market rows; that is a miss, not a finding.